PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1997 November; 90(11): 612–617.
PMCID: PMC1296671

Escherichia coli and ulcerative colitis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • SENECA H, HENDERSON E. Normal intestinal bacteria in ulcerative colitis. Gastroenterology. 1950 May;15(11):34–39. [PubMed]
  • Cooke EM. Properties of strains of Escherichia coli isolated from the faeces of patients with ulcerative colitis, patients with acute diarrhoea and normal persons. J Pathol Bacteriol. 1968 Jan;95(1):101–113. [PubMed]
  • Gorbach SL, Nahas L, Plaut AG, Weinstein L, Patterson JF, Levitan R. Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy. Gastroenterology. 1968 Apr;54(4):575–587. [PubMed]
  • Cooke EM, Ewins SP, Hywel-Jones J, Lennard-Jones JE. Properties of strains of Escherichia coli carried in different phases of ulcerative colitis. Gut. 1974 Feb;15(2):143–146. [PMC free article] [PubMed]
  • Dickinson RJ, Varian SA, Axon AT, Cooke EM. Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis. Gut. 1980 Sep;21(9):787–792. [PMC free article] [PubMed]
  • Burke DA, Axon AT. Ulcerative colitis and Escherichia coli with adhesive properties. J Clin Pathol. 1987 Jul;40(7):782–786. [PMC free article] [PubMed]
  • Burke DA, Axon AT. HeLa cell and buccal epithelial cell adhesion assays for detecting intestinal Escherichia coli with adhesive properties in ulcerative colitis. J Clin Pathol. 1987 Dec;40(12):1402–1404. [PMC free article] [PubMed]
  • Giaffer MH, Holdsworth CD, Duerden BI. Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut. 1992 May;33(5):646–650. [PMC free article] [PubMed]
  • Burke DA, Axon AT. Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea. BMJ. 1988 Jul 9;297(6641):102–104. [PMC free article] [PubMed]
  • Burke DA, Clayden SA, Axon AT. Sulphasalazine does not select for Escherichia coli with adhesive properties in ulcerative colitis. Lancet. 1988 Oct 22;2(8617):966–966. [PubMed]
  • Ljungh A, Eriksson M, Eriksson O, Henter JI, Wadström T. Shiga-like toxin production and connective tissue protein binding of Escherichia coli isolated from a patient with ulcerative colitis. Scand J Infect Dis. 1988;20(4):443–446. [PubMed]
  • Dickinson RJ, Branch WJ, Warren RE, Neale G. Rectal organ culture as a model for the investigation of bacterial adhesion and invasion. J Clin Pathol. 1984 May;37(5):587–591. [PMC free article] [PubMed]
  • Ohkusa T, Okayasu I, Tokoi S, Ozaki Y. Bacterial invasion into the colonic mucosa in ulcerative colitis. J Gastroenterol Hepatol. 1993 Jan-Feb;8(1):116–118. [PubMed]
  • Burke DA, Clayden SA, Axon AT. Serum bactericidal resistance of faecal Escherichia coli and bactericidal competence of serum from patients with ulcerative colitis. J Clin Pathol. 1990 Apr;43(4):316–319. [PMC free article] [PubMed]
  • Hunt CM, Harvey JA, Youngs ER, Irwin ST, Reid TM. Clinical and pathological variability of infection by enterohaemorrhagic (Vero cytotoxin producing) Escherichia coli. J Clin Pathol. 1989 Aug;42(8):847–852. [PMC free article] [PubMed]
  • von Wulffen H, Rüssmann H, Karch H, Meyer T, Bitzan M, Kohrt TC, Aleksic S. Verocytotoxin-producing Escherichia coli O2:H5 isolated from patients with ulcerative colitis. Lancet. 1989 Jun 24;1(8652):1449–1450. [PubMed]
  • Tabaqchali S, O'Donoghue DP, Bettelheim KA. Escherichia coli antibodies in patients with inflammatory bowel disease. Gut. 1978 Feb;19(2):108–113. [PMC free article] [PubMed]
  • Perlmann P, Hammarström S, Lagercrantz R, Gustafsson BE. Antigen from colon of germfree rats and antibodies in human ulcerative colitis. Ann N Y Acad Sci. 1965 Jun 30;124(1):377–394. [PubMed]
  • KOFFLER D, MINKOWITZ S, ROTHMAN W, GARLOCK J. Immunocytochemical studies in ulcerative colitis and regional ileitis. Am J Pathol. 1962 Dec;41:733–745. [PubMed]
  • Kemler BJ, Alpert E. Inflammatory bowel disease: study of cell mediated cytotoxicity for isolated human colonic epithelial cells. Gut. 1980 May;21(5):353–359. [PMC free article] [PubMed]
  • Onderdonk AB, Bartlett JG. Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr. 1979 Jan;32(1):258–265. [PubMed]
  • Van der Waaij D, Cohen BJ, Anver MR. Mitigation of experimental inflammatory bowel disease in guinea pigs by selective elimination of the aerobic gram-negative intestinal microflora. Gastroenterology. 1974 Sep;67(3):460–472. [PubMed]
  • Watt J, Marcus SN, Marcus AJ. The comparative prophylactic effects of sulphasalazine, prednisolone and azathioprine in experimental colonic ulceration. J Pharm Pharmacol. 1980 Dec;32(12):873–874. [PubMed]
  • KRAFT SC, FITCH FW, KIRSNER JB. HISTOLOGIC AND IMMUNOHISTOCHEMICAL FEATURES OF THE AUER "COLITIS" IN RABBITS. Am J Pathol. 1963 Dec;43:913–927. [PubMed]
  • Mee AS, McLaughlin JE, Hodgson HJ, Jewell DP. Chronic immune colitis in rabbits. Gut. 1979 Jan;20(1):1–5. [PMC free article] [PubMed]
  • Cooke EM, Filipe MI, Dawson IM. The production of colonic auto-antibodies in rabbits by immunisation with Escherichia coli. J Pathol Bacteriol. 1968 Jul;96(1):125–130. [PubMed]
  • Onderdonk AB, Steeves RM, Cisneros RL, Bronson RT. Adoptive transfer of immune enhancement of experimental ulcerative colitis. Infect Immun. 1984 Oct;46(1):64–67. [PMC free article] [PubMed]
  • Cave DR, Mitchell DN, Brooke BN. Evidence of an agent transmissible from ulcerative colitis tissue. Lancet. 1976 Jun 19;1(7973):1311–1315. [PubMed]
  • Taub RN, Sachar D, Siltzbach LE, Janowitz H. Transmission of ileitis and sarcoid granulomas to mice. Trans Assoc Am Physicians. 1974;87:219–224. [PubMed]
  • Davies PS, Rhodes J, Heatley RV, Owen E. Metronidazole in the treatment of chronic proctitis: a controlled trial. Gut. 1977 Aug;18(8):680–681. [PMC free article] [PubMed]
  • Chapman RW, Selby WS, Jewell DP. Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut. 1986 Oct;27(10):1210–1212. [PMC free article] [PubMed]
  • Dickinson RJ, Varian SA, Axon AT, Cooke EM. Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis. Gut. 1980 Sep;21(9):787–792. [PMC free article] [PubMed]
  • Hartley MG, Hudson MJ, Swarbrick ET, Grace RH, Gent AE, Hellier MD. Sulphasalazine treatment and the colorectal mucosa-associated flora in ulcerative colitis. Aliment Pharmacol Ther. 1996 Apr;10(2):157–163. [PubMed]
  • West B, Lendrum R, Hill MJ, Walker G. Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease. Gut. 1974 Dec;15(12):960–965. [PMC free article] [PubMed]
  • Burke DA, Axon AT, Clayden SA, Dixon MF, Johnston D, Lacey RW. The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther. 1990 Apr;4(2):123–129. [PubMed]
  • Lobo AJ, Burke DA, Sobala GM, Axon AT. Oral tobramycin in ulcerative colitis: effect on maintenance of remission. Aliment Pharmacol Ther. 1993 Apr;7(2):155–158. [PubMed]
  • McCann ML, Abrams RS, Nelson RP., Jr Recolonization therapy with nonadhesive Escherichia coli for treatment of inflammatory bowel disease. Ann N Y Acad Sci. 1994 Aug 15;730:243–245. [PubMed]
  • Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet. 1989 Jan 21;1(8630):164–164. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press